Precision therapies take aim at non-Hodgkin’s lymphoma
Elie Dolgin • November 14, 2018
The dramatic success of ibrutinib has created a more hopeful reality for people with lymphoma, as targeted therapies fill the pipeline.
Continue reading here.
Enhanced cryo–electron microscopy promises to bring previously elusive proteins into view.
AI-guided redesign of protein alphabet in bacteria could unlock new ways to build synthetic organisms.